Product Overview

Alternative Name: SCHIELD Biodegradable MPT Implant

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Subdermal

Duration Type: Long-acting

Description: The SCHIELD implant will be designed for sustained, long-acting delivery of API, capable of dual indication (anti-retroviral plus contraceptive) with zero-order release kinetics. This biodegradable, reversible implant will be subcutaneously placed, discrete, and user-independent to eliminate patient burden.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Early Development

Project Stage: Pre-clinical

Began discovery in: July 2017

Status Details:
  • This product is still in the early development phase. The API screening and formulations are currently underway, as well as implant fabrication and prototyping.

Download Product Report